This study describes the development of an in vitro electroporation technique that allows for the manipulation of gene expression in the lower rhombic lip of midgestation embryos.
The rhombic lip is an embryonic neuroepithelium located in the hindbrain at the junction between the neural tube and the roofplate of the fourth ventricle (reviewed in 1). The rhombic lip can be subdivided into the upper rhombic lip (URL) which encompasses rhombomere 1 (r1) and generates neurons of the cerebellum and the lower rhombic lip (LRL) which gives rise to diverse neuronal brainstem lineages 2-4. LRL derivatives include the auditory neurons of the cochlear nuclei and those of the precerebellar nuclei that are involved in regulating balance and motor control 5-8. Neurogenesis from the LRL occurs over a large temporal window that encompasses embryonic days (E) 9.5-16.55, 9. Different neuronal lineages emerge from the LRL as postmitotic cells (or are born) during distinct developmental days during this neurogenic window.
Electroporation of gene expression constructs can be used to manipulate gene expression in LRL progenitors and can potentially change the fate of the neurons produced from this region 10-12. Altering gene expression of LRL progenitors in the mouse via in utero electroporation has been highly successful for manipulating lineages born on embryonic day E12.5 or later 10, 12-14. In utero electroporations prior to E12.5 have been unsuccessful primarily due to the lethality associated with puncturing the fourth ventricle roofplate, a necessary step in delivering exogenous DNA that is electroporated into the LRL. However, many LRL derived lineages arise from the LRL earlier than E12.5 9. These earlier born lineages include the neurons that comprise the lateral reticular, external cuneate, and inferior olivary nuclei of the precerebellar system which function to connect inputs from the spinal cord and cortex to the cerebellum 5. In order to manipulate expression in the LRL of embryos younger than E12.5, we developed an in vitro system in which embryos are placed into culture following electroporation.
This study presents an efficient and effective method for manipulating the gene expression of LRL progenitors at E11.5. Embryos electroporated with green fluorescent protein (GFP) driven from the broadly active CAG promoter reproducibly expressed GFP after 24 hours of culture. A critical aspect of this assay is that gene expression is only altered because of the expression of the exogenous gene and not because of secondary effects that result from the electroporation and culturing techniques. It was determined that the endogenous gene expression patterns remain undisturbed in electroporated and cultured embryos. This assay can be utilized to alter the fate of cells emerging from the LRL of embryos younger than E12.5 through the introduction of plasmids for overexpression or knock down (through RNAi) of different pro-neural transcription factors.
1. Preparations Prior to Electroporation
2. Embryonic Harvest
3. Electroporation of E11.5 Embryos (Figure 1)
4. Culture of Embryos
5. Preparation of Embryos for Analysis
6. Immunohistochemistry Analysis
7. Representative Results
A schematic in Figure 1A depicts the electroporation experiment. Figure 1B shows a sagittal view of an E11.5 embryo prior to manipulation. The same embryo following injection of the plasmid containing CAG::GFP in 0.01% Fast Green is shown in Figure 1C and a representative unfixed embryo exhibiting unilateral GFP expression in the dorsal hindbrain 24 hr following culture is shown in Figure 1D. The extent of the area of the LRL that is successfully electroporated is variable and appears to be highly dependent on positioning of the electrodes. In our studies it was found that 52 out of 65 (80%) of the electroporated embryos successfully expressed GFP. Tissue was deemed to be successfully electroporated if it was positive for GFP in localized regions over several sections following fixation and immunohistochemical analysis (see below). Embryos that failed to meet this criteria were scored as unsuccessful attempts at electroporation.
Further assessment of electroporation efficiency can be ascertained by performing immunohistochemistry against GFP on transverse sections of electroporated embryos at the level of the fourth ventricle. Figure 2 shows representative serial sections from an embryo displaying unilateral GFP expression. Figure 2A shows an idealized schematic that illustrates that the left side of the embryo was toward the positive electrode. Transverse sections (at levels represented by the middle cartoon of Figure 2A) reveal localized GFP expression exclusively on the left side of the hindbrain tissue (Figures 2C and 2D). The electroporated area of the LRL did not extend the entire anterior-posterior axis of the neural tube as examination of sections 300 μm rostral or greater to that shown in Figure 2C does not express GFP (Figure 2B).
The utility of this assay for manipulation of gene expression is dependent upon the stability of the expression domains for the endogenous proteins. The LRL has been characterized as possessing unique progenitor domains characterized by the differential expression of proneural transcription factors (reviewed in 1). A subset of these factors (Mash1, Math1, Ngn1, and Ptf1a) were chosen for analysis due to their proposed and/or characterized roles in the specification of precerebellar neural subtypes in the LRL, a subject of future studies 16-18. All four proteins have highly characteristic expression domains in the caudal hindbrain at E11.5 16-18. We observed that embryos that were placed cultures failed to increase in size and also failed to initiate production of choroid plexus epithelium and invagination of the LRL and roofplate, morphological events that occur between E11.5 and E12.5 5. Based on these observations it was determined that normal development in these embryos was halted or grossly delayed and the comparable control for the cultured embryos should be uncultured embryos at E11.5.
To ensure that culture and electroporation do not disturb levels of endogenous proteins, we analyzed four different proteins by immunohistochemistry (IHC) in 34 different embryos that were electroporated and then cultured for at least 24 hr. Table I shows the number of embryos analyzed for each marker and the percentage of the embryos analyzed that retained normal protein levels. Figure 3 shows representative IHC data from two of the proteins analyzed, Mash1 (Figures 3A and 3B) and Math1 (Figures 3C and 3D). We observed that the majority of the embryos retained normal levels of expression following electroporation and culture (Figures 3B and 3D) as compared to the control embryos at E11.5 (Figures 3A and 3C). Importantly, the characteristic expression domains of these proteins were not perturbed.
Figure 1. Electroporation of Embryos at E11.5. (A) Schematic of the electroporation experiment. An E11.5 embryo is isolated and the expression plasmid in 0.01% Fast Green is injected into the fourth ventricle. The embryo is then flanked by electrode paddles and subjected to a 50 V pulse prior to being placed into culture (B) Sagittal view of an E11.5 embryo prior to injection. (C) The same E11.5 embryo following injection of plasmid in 0.01% Fast Green. (D) Unilateral hindbrain expression of GFP observed in E11.5 embryo following 24 hr of culture. mb- midbrain; 4v- fourth ventricle.
Figure 2. Expression of GFP in Electroporated Tissue. (A) The cartoon on left depicts the placement of electrodes around an E11.5 embryo. Middle cartoon depicts uptake and expression of plasmid encoding GFP on the left side of the embryo. Cartoon on right is schematic of an idealized transverse section taken through the embryo at levels denoted by black lines in middle cartoon. (B−D) Immunohistochemistry for GFP on transverse sections through an electroporated E11.5 embryo after 24 hr of culture. Arrows indicate the roofplate (rp) which traps the secondary antibody. Images are taken at 10X magnification. The relative levels of the sections shown are depicted by the horizontal lines through the middle cartoon in (A). mb- midbrain;l 4v- fourth ventricle; rp- roofplate.
Figure 3. Expression of Endogenous Proteins in the Lower Rhombic Lip. Immunohistochemistry for Mash1 (A and B) or Math1 (C and D) comparing transverse sections of E11.5 embryos that were not cultured (A, C) with embryos that were electroporated with CAG::GFP and cultured for 24 hr (B and D). Images taken at 10X magnification.
Proneural Transcription Factor Analyzed | Number of Embryos Analyzed | Percentage Retaining Normal Expression Patterns |
Math1 | 15 | 86.7% |
Mash1 | 12 | 83.3% |
Ngn1 | 7 | 71.4% |
Ptf1a | 6 | 100% |
Table I. Percentage of Electroporated and Cultured Embryos Retaining Normal Proneural Transcription Factor Domains in the LRL.
The in vitro electroporation technique presented in this study is a novel methodology that can be efficiently utilized to manipulate gene expression in embryos younger than 12 days of gestation. Placement of the embryos into culture permits expression of the introduced gene and circumvents the lethality observed when electroporated embryos are allowed to remain in vivo. This technique allows for the manipulation of gene expression in embryonic progenitors that were previously inaccessible for electroporation-based studies.
The electroporation technique resulted in efficient expression of the introduced gene in 80% of the embryos analyzed. As observed in Figure 2 the extent of electroporated tissue is localized to discrete regions. In order to specifically target a particular hindbrain region for electroporation the electrodes must be carefully placed as this governs the location of affected tissue. If the lower rhombic lip of the dorsal embryonic hindbrain is desired, paddles must be place such that they are directly flanking the widest part of the fourth ventricle opening. If unilateral expression on one side of the neural tube is desired then the embryo needs to be positioned between the electrodes such that the axis of the neural tube is parallel to the paddles. Tilting of the embryo can result in improper targeting and/or bilateral expression. In optimizing to achieve better electroporation efficiency one could vary the electroporation voltage as this might increase the proportion of cells that uptake the electroporated DNA. One could also further concentrate the DNA stocks. As the neural tube can only accommodate a small volume of liquid, more concentrated samples should increase the amount of plasmid introduced into the cells upon electroporation. Finally, one could change the diameter of the paddles. If one wants to target a smaller and more localized region it might be best to decrease the paddle size.
Critical to the utility of this technique in manipulating hindbrain gene expression is the retention of normal gene and protein expression patterns following electroporation and culture of embryos. As documented in Figure 3 and Table I, normal proneural transcription factor levels and patterns are well retained 83% of the embryos analyzed expressed Mash1, 86% expressed Math1, and 100% expressed Ptf1a. Levels of Ngn1 were not as robustly retained (71%) as the other transcription factors assayed. While it is possible that this particular transcription factor is adversely affected by the electroporation and culture procedure we believe that there is an alternative explanation. It has been shown that Ngn1 expression in the dorsal hindbrain diminishes over time, with levels disappearing by embryonic day (E) 12.5 16. Given that the percentage of embryos expressing Ngn1 is lower than those retaining normal expression for the other proteins assessed (83% or greater) it is possible that at least a portion of the 30% of embryos that are deficient in the expression of dorsal Ngn1 have progressed in the normal developmental program, turning off Ngn1 expression 24 hr after harvest at E11.5 and placement into culture. This suggests that molecular changes that occur in the dorsal hindbrain between E11.5 and E12.5 might occur in a portion of the embryos but does so on an asynchronous or delayed time frame. This finding merits further analysis in future studies but does not diminish the enthusiasm for this assay. The possibility that embryos might be undergoing molecular changes that occur during the normal development should also inform how results from studies utilizing this technique are interpreted.
Variations to the optimized electroporation and culture conditions presented in this study are possible. It was found that 50 V gave a robust uptake of the electroporated gene with minimal disturbance to tissue integrity. The voltage for the electroporations can be modified in order to fine-tune this assay to individual experimenter’s needs. The culture conditions were optimized on embryos that were directly placed into culture media (described above) in a 12-well plate. This technique can be modified by placing the embryo onto a membrane (Costar) that is placed into the media of a 12-well plate. During optimization of the culturing technique this variation was attempted but it did not appear to significantly affect the experimental outcome either in electroporated gene expression or retention of normal gene expression patterns.
This study focused on culturing embryos for 24 hours. Embryos have been cultured for up to 48 hr with the media being changed at 24 hr. It was found that the integrity of the tissue declined with longer incubation times but expression of electroporated GFP could be detected. For longer incubation times (past 48 hr) it might be necessary change the culture conditions and will likely be the subject of future investigations.
During optimization of culture the assay it was found that retention of endogenous gene expression improved in embryos that had greater exposure of the neural tube to the media environment. In these studies this was achieved by puncture of the 4th ventricle roofplate and removal extraneous tissue in the caudal portion of the embryo prior to placement in culture. Future studies will investigate if microdissected neural tube can be successfully cultured under these conditions.
This study focused on electroporation of embryos at 11.5 days of gestation (E11.5). A future direction would be to optimize the technique for earlier stages of development. We have used this technique on embryos harvested at E10.5 and while we have yet to accumulate and analyze a significant numbers of embryos we have seen success in introducing GFP and culturing the embryos. A more in depth further study would be necessary to say with certainty that the technique used in this study could be applied to younger embryos. It might be possible to electroporate embryos younger than E10.5 but it has not been attempted.
A functional application of this technique could be to overexpress or knock down the function of genes to investigate if their protein products are critical to the production of different neural subtypes from the LRL. Future experiments with this technique will focus on the introduction of proneural transcription factors to alter the fate of the different neural subypes known to be produced from the LRL at E11.5. The technique could also be adapted to target other neuroepithelial regions that are actively producing neurons at E11.5.
The authors have nothing to disclose.
The authors would like to thank Jane Johnson for the Math1, Ngn1, and Ptf1a antibodies and Connie Cepko for the pCAG::GFP plasmid. This work was funded by NIH R15 1R15HD059922-01.
Name of the reagent | Company | Catalogue number | Comments (optional) |
Cryostat | Leica | CM-1850 | |
Biologie tip Dumoxel treated DUMONT forceps | Fine Scientific Tools | 11252-30 | |
20 mm MORIA perforated spoon | Fine Scientific Tools | 10370-17 | |
ECM 830 Square Wave Electroporation Generator | BTX (VWR) | 47745-928 | |
Harvard Apparatus 7 mm Tweezertrodes* Electrodes | BTX (Fisher) | BTX450165 | |
Fisher Isotemp CO2 Incubator | Fisher | 1325525 | |
NAPCO CO2 Gas Regulator | Fisher | 15497020 | |
12 Well Tissue Culture Plates | BD Falcon (Fisher) | 877229 | |
HyClone Liquid Media DMEM/F-12 (1:1); With L-Glutamine and HEPES; 500mL | Thermo Scientific (Fisher) | SH3002301 | |
HyClone* Donor Equine Serum | Thermo Scientific (Fisher) | SH3007402 | |
Fetal Bovine Serum, Qualified, Heat Inactivated | Invitrogen | 16140-063 | |
cellgro* 10,000 IU Penicillin, 10,000μg/mL Streptomycin | Mediatech (Fisher) | MT-30-002-CI | |
HyClone* L-Glutamine L-Glutamine; 200mM in 0.85% NaCl | Thermo Scientific (Fisher) | SH3003401 | |
Fast-Green | Fisher | AC41053-0250 | 0.01% |